JP2025156297A5 - - Google Patents
Info
- Publication number
- JP2025156297A5 JP2025156297A5 JP2025072308A JP2025072308A JP2025156297A5 JP 2025156297 A5 JP2025156297 A5 JP 2025156297A5 JP 2025072308 A JP2025072308 A JP 2025072308A JP 2025072308 A JP2025072308 A JP 2025072308A JP 2025156297 A5 JP2025156297 A5 JP 2025156297A5
- Authority
- JP
- Japan
- Prior art keywords
- invention described
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19166428.3 | 2019-03-29 | ||
| EP19166428 | 2019-03-29 | ||
| EP19188971 | 2019-07-30 | ||
| EP19188971.6 | 2019-07-30 | ||
| PCT/US2020/025166 WO2020205493A1 (en) | 2019-03-29 | 2020-03-27 | Fgfr tyrosine kinase inhibitors for the treatment of urothelial carcinoma |
| JP2021557924A JP7747521B2 (ja) | 2019-03-29 | 2020-03-27 | 尿路上皮癌の治療のためのｆｇｆｒチロシンキナーゼ阻害剤 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021557924A Division JP7747521B2 (ja) | 2019-03-29 | 2020-03-27 | 尿路上皮癌の治療のためのｆｇｆｒチロシンキナーゼ阻害剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025156297A JP2025156297A (ja) | 2025-10-14 |
| JP2025156297A5 true JP2025156297A5 (https=) | 2025-12-04 |
Family
ID=70296138
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021557924A Active JP7747521B2 (ja) | 2019-03-29 | 2020-03-27 | 尿路上皮癌の治療のためのｆｇｆｒチロシンキナーゼ阻害剤 |
| JP2025072308A Pending JP2025156297A (ja) | 2019-03-29 | 2025-04-24 | 尿路上皮癌の治療のためのｆｇｆｒチロシンキナーゼ阻害剤 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021557924A Active JP7747521B2 (ja) | 2019-03-29 | 2020-03-27 | 尿路上皮癌の治療のためのｆｇｆｒチロシンキナーゼ阻害剤 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20220054484A1 (https=) |
| EP (1) | EP3946341A1 (https=) |
| JP (2) | JP7747521B2 (https=) |
| KR (1) | KR20210145211A (https=) |
| CN (1) | CN113645974A (https=) |
| AU (1) | AU2020253827B2 (https=) |
| BR (1) | BR112021019446A2 (https=) |
| CA (1) | CA3130460A1 (https=) |
| IL (1) | IL286729A (https=) |
| JO (1) | JOP20210266A1 (https=) |
| MA (1) | MA55522A (https=) |
| MX (1) | MX2021011926A (https=) |
| PH (1) | PH12021552342A1 (https=) |
| SG (1) | SG11202109902SA (https=) |
| WO (1) | WO2020205493A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4719420A1 (en) * | 2023-05-24 | 2026-04-08 | Janssen Pharmaceutica NV | Treatment of locally advanced or metastatic urothelial carcinoma with erdafinitib |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4666828A (en) | 1984-08-15 | 1987-05-19 | The General Hospital Corporation | Test for Huntington's disease |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4801531A (en) | 1985-04-17 | 1989-01-31 | Biotechnology Research Partners, Ltd. | Apo AI/CIII genomic polymorphisms predictive of atherosclerosis |
| US5033252A (en) | 1987-12-23 | 1991-07-23 | Entravision, Inc. | Method of packaging and sterilizing a pharmaceutical product |
| US5052558A (en) | 1987-12-23 | 1991-10-01 | Entravision, Inc. | Packaged pharmaceutical product |
| US5272057A (en) | 1988-10-14 | 1993-12-21 | Georgetown University | Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase |
| US5192659A (en) | 1989-08-25 | 1993-03-09 | Genetype Ag | Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes |
| US5323907A (en) | 1992-06-23 | 1994-06-28 | Multi-Comp, Inc. | Child resistant package assembly for dispensing pharmaceutical medications |
| EP0951541B1 (en) | 1995-07-31 | 2005-11-30 | Urocor, Inc. | Biomarkers and targets for diagnosis, prognosis and management of prostate disease |
| US6218529B1 (en) | 1995-07-31 | 2001-04-17 | Urocor, Inc. | Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer |
| GB0512324D0 (en) | 2005-06-16 | 2005-07-27 | Novartis Ag | Organic compounds |
| BRPI0611375A2 (pt) | 2005-05-23 | 2010-08-31 | Novartis Ag | formas cristalinas e outras de sais de ácido láctico de 4-amino-5-flúor-3-[6-(4-metilpiperazin-1-il)-1h-benzimid azol-2-il]-1h-quinolin-2-ona |
| US8163923B2 (en) | 2007-03-14 | 2012-04-24 | Advenchen Laboratories, Llc | Spiro substituted compounds as angiogenesis inhibitors |
| GB201007286D0 (en) | 2010-04-30 | 2010-06-16 | Astex Therapeutics Ltd | New compounds |
| KR102470456B1 (ko) | 2014-09-26 | 2022-11-23 | 얀센 파마슈티카 엔.브이. | Fgfr 억제제를 사용한 치료에 반응할 암 환자를 확인하는 데 있어서 fgfr 돌연변이 유전자 패널의 사용 |
| US10208024B2 (en) * | 2015-10-23 | 2019-02-19 | Array Biopharma Inc. | 2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases |
| HUE062453T2 (hu) | 2017-02-06 | 2023-11-28 | Janssen Pharmaceutica Nv | Rákbetegség kezelése |
| SG11201906249PA (en) | 2017-02-06 | 2019-08-27 | Rainier Therapeutics Inc | Methods, compositions, and kits for treatment of cancer |
| TWI798199B (zh) * | 2017-02-06 | 2023-04-11 | 比利時商健生藥品公司 | 癌症治療 |
| JOP20190280A1 (ar) * | 2017-06-02 | 2019-12-02 | Janssen Pharmaceutica Nv | مثبطات fgfr2 لعلاج سرطان الأوعية الصفراوية |
-
2020
- 2020-03-27 PH PH1/2021/552342A patent/PH12021552342A1/en unknown
- 2020-03-27 US US17/599,729 patent/US20220054484A1/en active Pending
- 2020-03-27 JP JP2021557924A patent/JP7747521B2/ja active Active
- 2020-03-27 WO PCT/US2020/025166 patent/WO2020205493A1/en not_active Ceased
- 2020-03-27 CN CN202080025860.4A patent/CN113645974A/zh active Pending
- 2020-03-27 EP EP20720283.9A patent/EP3946341A1/en active Pending
- 2020-03-27 CA CA3130460A patent/CA3130460A1/en active Pending
- 2020-03-27 MX MX2021011926A patent/MX2021011926A/es unknown
- 2020-03-27 AU AU2020253827A patent/AU2020253827B2/en active Active
- 2020-03-27 KR KR1020217034721A patent/KR20210145211A/ko not_active Ceased
- 2020-03-27 MA MA055522A patent/MA55522A/fr unknown
- 2020-03-27 SG SG11202109902S patent/SG11202109902SA/en unknown
- 2020-03-27 BR BR112021019446A patent/BR112021019446A2/pt unknown
-
2021
- 2021-09-26 JO JOP/2021/0266A patent/JOP20210266A1/ar unknown
- 2021-09-26 IL IL286729A patent/IL286729A/en unknown
-
2025
- 2025-04-24 JP JP2025072308A patent/JP2025156297A/ja active Pending